Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.689
+0.036 (5.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
Predictive Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 13 | 24 | 62 | 13 | 10 | |
| Market Cap Growth | -59.24% | -44.64% | -61.32% | 382.16% | 26.38% | 17.42% | |
| Enterprise Value | 4 | 5 | -1 | 22 | 18 | 16 | |
| Last Close Price | 0.65 | 3.29 | 6.13 | 19.04 | 14.65 | 52.20 | |
| PS Ratio | 2.11 | 7.51 | 16.04 | 43.94 | 10.34 | 7.26 | |
| PB Ratio | 2.21 | 1.62 | 1.11 | 1.55 | 4.90 | 0.91 | |
| P/TBV Ratio | 3.01 | 1.67 | 1.12 | 2.12 | - | - | |
| EV/Sales Ratio | 2.47 | 2.59 | - | 15.26 | 14.39 | 11.01 | |
| Debt / Equity Ratio | 1.22 | 0.35 | 0.01 | 0.02 | 2.22 | 0.49 | |
| Asset Turnover | 0.12 | 0.09 | 0.04 | 0.05 | 0.07 | 0.11 | |
| Inventory Turnover | 1.70 | 1.37 | 1.23 | 1.44 | 1.86 | 2.47 | |
| Quick Ratio | 0.93 | 2.29 | 5.77 | 8.81 | 0.10 | 0.04 | |
| Current Ratio | 1.20 | 2.55 | 6.02 | 9.09 | 0.16 | 0.07 | |
| Return on Equity (ROE) | -201.46% | -93.11% | -82.98% | -91.62% | -373.14% | -343.66% | |
| Return on Assets (ROA) | -66.44% | -43.34% | -27.46% | -29.63% | -44.04% | -62.86% | |
| Return on Capital (ROIC) | -88.93% | -52.61% | -30.25% | -33.91% | -61.74% | -88.90% | |
| Earnings Yield | -321.08% | -104.61% | -106.59% | -31.49% | -199.94% | -189.28% | |
| FCF Yield | -301.96% | -100.73% | -52.97% | -21.02% | -96.99% | -85.30% | |
| Buyback Yield / Dilution | -20.51% | -8.92% | -34.34% | -359.21% | -316.36% | -123.95% | |
| Total Shareholder Return | -20.51% | -8.92% | -34.34% | -359.21% | -316.36% | -123.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.